Target intelligence / Profile preview

Cyclic AMP-responsive element-binding protein 1 (CREB)

Target
CREB
Molecular classification
Transcription factor, Leucine zipper protein
01

Overview

Cyclic AMP-responsive element-binding protein (CREB) is a phosphorylation-dependent transcription factor that regulates gene expression in response to various extracellular signals. It binds to specific DNA sequences known as cAMP response elements (CRE), thereby modulating the transcription of numerous genes involved in diverse cellular processes. Activation involves phosphorylation at Ser133, leading to recruitment of coactivators like CBP and enhanced gene transcription. CREB plays a central role in regulating genes involved in cell proliferation, differentiation, survival, neuronal plasticity, neurogenesis, long-term synaptic potentiation, circadian rhythm synchronization, and adipocyte differentiation. Dysregulation of CREB is implicated in cancer, mental disorders, and cardiovascular disease.

Other names
CREB1
02

Mechanism of action

CREB activity is modulated by phosphorylation, primarily at Ser133, leading to recruitment of coactivators such as CBP and subsequent transcriptional activation of target genes. Drugs can indirectly target CREB by modulating upstream kinases (e.g., PKA, CaMKs, MAPKs) or phosphatases that regulate its phosphorylation state. Direct CREB inhibitors are also being explored.

03

Biological functions

Cell proliferationCell differentiationCell survivalNeuronal plasticityNeurogenesisLong-term synaptic potentiationCircadian rhythm synchronizationAdipocyte differentiationRegulation of apoptosisRegulation of inflammatory responsesHormone secretionMetabolism
04

Disease associations

CancerLeukemiaHepatocellular carcinomaMental disordersSchizophreniaCardiovascular diseaseInflammation
05

Safety considerations

Dysregulation of CREB can promote tumor growth and resistance to apoptosis.Altered CREB signaling is linked to mental disorders.CREB contributes to inflammation and cell death in cardiovascular diseases.

Beyond the preview

Go deeper on Cyclic AMP-responsive element-binding protein 1 (CREB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclic AMP-responsive element-binding protein 1 (CREB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call